Furthermore, we identified a positive correlation between Steap4 expression and IL-22 levels in HCC tissue in vivo, thus identifying a possible downstream mechanism regarding IL-22 and hepatocyte proliferation. This evidence concerns the gene IL22 and hepatocellular carcinoma.